| (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide | |
| Other names： | Nazartinib; EGF816; NVS-816 |
| Cas No： | 1508250-71-2 |
| Molecular formula： | C26H31ClN6O2 |
| Molecular weight： | 49502 |
| Purity： | 98% |
| (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide | |
| Other names： | Nazartinib; EGF816; NVS-816 |
| Cas No： | 1508250-71-2 |
| Molecular formula： | C26H31ClN6O2 |
| Molecular weight： | 49502 |
| Purity： | 98% |
| (R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide | |
| Other names： | Nazartinib; EGF816; NVS-816 |
| Cas No： | 1508250-71-2 |
| Molecular formula： | C26H31ClN6O2 |
| Molecular weight： | 49502 |
| Purity： | 98% |